Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (261-270 of 387) with videos related to

Pageof 39
Sort By:
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Annals of Hematology|July 21, 2010
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureSergio Siragusa, William Morice, Morie A Gertz, et al.
Blood|September 11, 2007
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphomaJames R Cerhan, Stephen M Ansell, Zachary S Fredericksen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.
Hemasphere|April 10, 2023
Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell TransplantAung M Tun, Yucai Wang, Aasiya Matin, et al.
American Journal of Hematology|September 20, 2018
The association of physical activity before and after lymphoma diagnosis with survival outcomesPriyanka A Pophali, Andrew Ip, Melissa C Larson, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.
Blood|February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institutionSaad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Pageof 39

Showing results (261-270 of 387) with videos related to

Sort By:
Pageof 39
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Annals of Hematology|July 21, 2010
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureSergio Siragusa, William Morice, Morie A Gertz, et al.
Blood|September 11, 2007
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphomaJames R Cerhan, Stephen M Ansell, Zachary S Fredericksen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.
Hemasphere|April 10, 2023
Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell TransplantAung M Tun, Yucai Wang, Aasiya Matin, et al.
American Journal of Hematology|September 20, 2018
The association of physical activity before and after lymphoma diagnosis with survival outcomesPriyanka A Pophali, Andrew Ip, Melissa C Larson, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.
Blood|February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institutionSaad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Pageof 39